Arcutis publishes long-term ZORYVE safety data for pediatric atopic dermatitis
Go back to Arcutis publishes long-term ZORYVE safety data for pediatric atopic dermatitis| (NASDAQ: ARQT) | Delayed: 26.22 -0.54 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.76 | 52 Week High | $ | |||
| Open | $27.15 | 52 Week Low | $ | |||
| Day High | $27.21 | P/E | N/A | |||
| Day Low | $25.83 | EPS | $ | |||
| Volume | 1,354,101 | |||||

